In this study, we retrospectively examined the expression of RIZ1 in 268 cervical cancer patients, and found that RIZ1 expression is negatively correlated with clinicopathological characteristics as well as clinical outcomes, including overall survival (OS) and disease-free survival (DFS). This evidence concerns the gene PRDM2 and cervical cancer.